IDEXX Laboratories, Inc. IDXX

519.26 5.87 1.14% as of 25 Sep
Market cap
$40.2B
P/E
36.2×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

IDEXX Laboratories, Inc. (IDXX) P/E ratio

As of 25 September 2026, IDEXX Laboratories, Inc. (IDXX) trades at a P/E ratio of 36.2×. Over the past ten years it has ranged from 31.2× (January 2016) to 85.8× (December 2020); the current reading is higher than 4% of that period. That is above the Diagnostics & Research industry median of 33.9× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 51.3× 33.71%
FY2024 38.4× (28.72%)
FY2023 53.9× 7.70%
FY2022 50.0× (33.63%)
FY2021 75.3× 2.64%
FY2020 73.4× 39.42%
FY2019 52.6× 22.55%
FY2018 43.0× (18.33%)
FY2017 52.6× 10.93%
FY2016 47.4× 34.94%

Quarterly

Period P/E ratio Change
Jun 2026 36.7× (10.43%)
Mar 2026 41.0× (20.10%)
Dec 2025 51.3× 2.12%
Sep 2025 50.3× 13.50%
42 more quarters

Against its own ten years

Low 31.2× High 85.8×
Ten-year median 51.6×
Current reading's percentile 4

P/E ratio against peers

Company P/E ratio
NTRA Natera, Inc. compare n/m
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 24.8×
IQV IQVIA Holdings Inc. compare 33.3×
MTD Mettler-Toledo International, Inc. compare 33.9×
A Agilent Technologies, Inc. compare 33.9×
IDXX IDEXX Laboratories, Inc. 36.2×
ILMN Illumina, Inc. compare 50.4×
WAT Waters Corporation compare 108×
Diagnostics & Research industry median 33.9×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on IDXX